To contribute to the understanding of the underlying neurobiological mechanism behind the interaction of alcohol and nalmefene
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
22
One single oral dose Nalmefene on Day 1 and Placebo on Day 8
One single oral dose Placebo on Day 1 and Nalmefene on Day 8
GB801
London, United Kingdom
Blood oxygen level dependent (BOLD) fMRI signal in the ventral striatum to reward responding using the monetary incentive delay task (MIDT) task
Time frame: Day 1
Safety
Number of adverse events
Time frame: Up to Day 8 and a 10-day safety follow up
Risk of suicidality
Columbia-Suicide Severity Rating Scale (CSSRS) score
Time frame: Up to Day 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.